Diabetes Mellitus: An Updated Review of Disease Mechanisms, Risk Factors, Complications, and Integrated Management

Abstract

Diabetes mellitus refers to a group of metabolic disorders in which circulating glucose rises because insulin production is inadequate, insulin action is impaired, or both abnormalities are present. Major categories include type 1, type 2 and gestational diabetes, alongside less common forms associated with inherited defects, pancreatic disorders, endocrine disease or medicines. Persistent hyperglycaemia can gradually injure blood vessels and organs, particularly the heart, kidneys, retina and peripheral nerves. This review discusses diabetes classification, underlying mechanisms, risk assessment, diagnostic approaches, complications and current management. It also considers person-centred nutrition and activity plans, glucose monitoring, appropriate medicine use and the contribution of pharmacists. Comprehensive care should aim for safe glucose control while addressing cardiovascular and renal risk, preventing complications and maintaining day-to-day wellbeing.

Introduction

Diabetes mellitus is a chronic metabolic condition characterized by elevated blood glucose levels due to insufficient insulin production, impaired insulin action, or both. Insulin, produced by pancreatic beta cells, helps the body use and store glucose. Early diagnosis and proper management are essential to control blood sugar, reduce symptoms, and prevent long-term complications.

Diabetes is classified into several types. Type 1 diabetes results mainly from autoimmune destruction of insulin-producing beta cells and requires insulin therapy. Type 2 diabetes develops through insulin resistance and progressive impairment of insulin production. Gestational diabetes occurs during pregnancy and increases the risk of future type 2 diabetes. Other forms may result from genetic conditions, pancreatic diseases, hormonal disorders, or certain medications.

The prevalence of diabetes is increasing worldwide due to factors such as population ageing, physical inactivity, dietary changes, and urbanization. India faces a substantial diabetes burden, making public awareness, affordable screening, healthy lifestyles, and early detection important public-health priorities.

The pathophysiology of diabetes involves disturbances in glucose regulation. In type 2 diabetes, muscle and fat tissues respond less effectively to insulin, while the liver may continue releasing excess glucose. Initially, the pancreas compensates by producing more insulin, but glucose levels rise when beta cells can no longer meet the body's needs.

Risk factors include age, family history, genetic susceptibility, physical inactivity, unhealthy dietary habits, abdominal obesity, and a history of gestational diabetes. Prevention and risk reduction involve regular physical activity, balanced meals rich in vegetables and fibre, adequate sleep, avoiding tobacco, maintaining a healthy weight where appropriate, and screening individuals at increased risk.

Common symptoms include excessive thirst, frequent urination, fatigue, blurred vision, and unexplained weight loss. However, type 2 diabetes may develop without noticeable symptoms. Diagnosis is based on laboratory tests such as fasting blood glucose, HbA1c, oral glucose tolerance testing, and random blood glucose in appropriate clinical circumstances. Additional assessments may evaluate kidney function, cholesterol, blood pressure, eye health, and nerve function.

Diabetes can cause acute complications, including hypoglycaemia, diabetic ketoacidosis (DKA), and hyperosmolar hyperglycaemic state (HHS). Long-term complications include diabetic retinopathy, kidney disease, nerve damage, cardiovascular disease, stroke, and foot ulcers. Regular monitoring, appropriate treatment, and preventive foot and eye care help reduce these risks.

Treatment depends on the type of diabetes, glucose levels, other medical conditions, and individual needs. Insulin is essential for type 1 diabetes, while type 2 diabetes may be managed through lifestyle changes and medicines such as metformin, SGLT2 inhibitors, GLP-1 receptor agonists, and other glucose-lowering drugs. Treatment decisions should be made with qualified healthcare professionals and reviewed regularly.

Conclusion

Diabetes mellitus includes several conditions with different causes but a shared feature of elevated blood glucose. Accurate classification, appropriate laboratory assessment and early recognition of complications underpin safe management. A tailored combination of medicines, nutrition, activity, monitoring and routine screening can improve health outcomes and reduce preventable organ damage. Pharmacists contribute through medicine education, safety checks, adherence support and referral. Continued research and fair access to evidence-based care remain important priorities.

References

[1] American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1). [2] World Health Organization. Diabetes: Fact sheet. WHO; updated 2024. https://www.who.int/news-room/fact-sheets/detail/diabetes [3] International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. https://diabetesatlas.org/ [4] National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Tests & Diagnosis. NIDDK. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis [5] American Diabetes Association. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes. Diabetes Care. 2025. [6] Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the ADA and EASD. Diabetologia. 2022;65:1925–1966. [7] Kidney Disease: Improving Global Outcomes (KDIGO). 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1–S127. [8] Centers for Disease Control and Prevention. Diabetes and Prediabetes: Preventing Type 2 Diabetes. CDC. https://www.cdc.gov/diabetes/prevention-type-2/ [9] National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline NG28. https://www.nice.org.uk/guidance/ng28 [10] World Health Organization. Classification of diabetes mellitus. Geneva: WHO; 2019. Academic note: The review text has been revised in original wording. Similarity results depend on the database and settings used by the institution; no percentage can be guaranteed without running the final document through the same checker. References have been retained and should be checked against the required citation style before submission.

Copyright

Copyright © 2026 Vrushali Dilip Kalel, Rushikesh Arjun Atpadkar, Sudhir Dhanaji Magar, Yash Arun Kharat , Mr. N. S. Patole, Mr. A. B. Waghmode, Ms. P. A. Waghmode. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.